- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Veridex, LLC
Total 11039 results
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Canada, Denmark, Poland, Switzerland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Belgium, Netherlands
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Australia, Ireland, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Belgium, Netherlands, United Kingdom, Australia, France, Canada, Denmark, Germany, Italy, Israel
-
Vertex Pharmaceuticals IncorporatedCompletedA Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following BunionectomyAcute PainUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom, Canada, Germany, Australia, France, Italy, Czechia, Austria, Greece, Sweden
-
Vertex Pharmaceuticals IncorporatedTerminatedCervical Spinal Cord InjuryUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, United Kingdom, Germany, Belgium, Austria, Ireland, Italy, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Australia, Canada, Germany, Switzerland, Israel, Netherlands, Belgium, Italy, United Kingdom, France
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, France, Spain, Israel, Australia, Austria
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada, Germany, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Belgium, Australia, Denmark, Canada, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, France, Spain, Belgium, Canada, Austria, Australia, Germany, United Kingdom, Denmark
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisUnited States, Estonia, Lithuania, South Africa
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisUnited States, Argentina, Bulgaria, Czech Republic, Estonia, Germany, Hungary, Mexico, Poland, Romania, Russian Federation, Serbia, Slovakia, Ukraine
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, France, United Kingdom, Germany, Australia, New Zealand, Belgium
-
Vertex Pharmaceuticals IncorporatedTerminated
-
Vertex Pharmaceuticals IncorporatedTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis CAustria, France, Germany, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedChronic Hepatitis C VirusUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedLung CancerUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedDrug InteractionsUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedRheumatoid ArthritisPoland, Belgium, Romania, Serbia, United States, Puerto Rico, Germany, Hungary, Russian Federation, Croatia
-
Vertex Pharmaceuticals IncorporatedCompletedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Acute Leukemia | Chronic LeukemiaUnited States
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, Canada, Australia
-
Vertex Pharmaceuticals IncorporatedRecruitingPainful Lumbosacral RadiculopathyUnited States
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Vertex Pharmaceuticals IncorporatedRecruitingType 1 DiabetesUnited States, Italy, United Kingdom, Canada, Switzerland, Netherlands, Germany
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Netherlands, United Kingdom, Canada, Australia, France, Germany, Italy, Czechia, Austria, Sweden, Greece
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingCystic FibrosisSpain, Belgium, Netherlands, France, Canada, Germany, Sweden, Switzerland, Italy, Czechia, Portugal, Austria, Hungary, Norway, Poland
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingAlpha-1 Antitrypsin DeficiencyUnited States, United Kingdom, Germany, Ireland
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Germany, United Kingdom, Canada, Australia, Switzerland, France, Ireland, Belgium, Denmark, Poland
-
Vertex Pharmaceuticals IncorporatedEnrolling by invitationCystic FibrosisUnited States, Australia, Germany, Sweden, Switzerland, France, Netherlands, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedAcute PainUnited States